Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells

Fertility and Sterility

Volumn 95, Issue 7, 2011, Pages 2383-2387

  McCarthy Keith, Desireé M ^a,b   Malik, Minnie ^b   Britten, Joy ^b   Segars, James ^a,b   Catherino, William H ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Leiomyoma; leuprolide acetate; myometrium; NFAT5; osmotic stress

Indexed keywords

ALDEHYDE REDUCTASE; LEUPRORELIN; MESSENGER RNA; RNA; SODIUM CHLORIDE; SODIUM MYO INOSITOL TRANSPORTER 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT5; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HOSPITAL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPEROSMOLARITY; LEIOMYOMA; LOW DRUG DOSE; MYOMETRIUM; OSMOSIS; OSMOTIC STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; T LYMPHOCYTE; WATER FLOW;

ALDEHYDE REDUCTASE; ANTINEOPLASTIC AGENTS, HORMONAL; CASE-CONTROL STUDIES; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GONADOTROPIN-RELEASING HORMONE; HEAT-SHOCK PROTEINS; HUMANS; LEIOMYOMA; LEUPROLIDE; OSMOTIC PRESSURE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS; WATER-ELECTROLYTE BALANCE;

EID: 79956348446     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.03.084     Document Type: Article

References (43)

1. D. Day Baird, D. Dunson, M. Hill, D. Cousins, and J. Schectman High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence Am J Obstet Gynecol 188 2003 100 107 (Pubitemid 36135604)
2. D. Selo-Ojeme, O. Lawal, J. Shah, R. Mandal, S. Pathak, and U. Selo-Ojeme The incidence of uterine leiomyoma and other pelvic ultrasonographic findings in 2,034 consecutive women in a north London hospital J Obstet Gynecol 28 2008 421 423 (Pubitemid 351950925)
3. R. Merrill Hysterectomy surveillance in the United States, 1997 through 2005 Med Sci Monit 14 2008 CR24 CR31
4. E. Pritts, W. Parker, and D. Olive Fibroids and infertility: an updated systematic review of the evidence Fertil Steril 91 2009 1215 1223
5. N. Bajekal, and T. Li Fibroids, infertility and pregnancy wastage Hum Reprod Update 6 2000 614 620
6. V.C. Buttram, and R.C. Reiter Uterine leiomyomata: etiology, symptomatology and management Fertil Steril 36 1981 433 445 (Pubitemid 11027013)
7. G.I. Qidwai, A.B. Caughey, and A.F. Jacoby Obstetric outcomes in women with sonographically identified uterine leiomyomata Obstet Gynecol 107 2006 376 382
8. G. Wegienka, D.D. Baird, I. Hertz-Picciotto, S.D. Harlow, J.F. Steege, and M.C. Hill Self-reported heavy bleeding associated with uterine leiomyomata Obstet Gynecol 101 2003 431 437 (Pubitemid 36288480)
9. S.A. Lippman, M. Warner, S. Samuels, D. Olive, P. Vercellini, and B. Eskenazi Uterine fibroids and gynecologic pain symptoms in a population-based study Fertil Steril 80 2003 1488 1494 (Pubitemid 37532467)
10. M. Flynn, M. Jamison, S. Datta, and E. Myers Health care resource use for uterine fibroid tumors in the United States Am J Obstet Gynecol 195 2006 955 964 (Pubitemid 44415640)
11. U.S. Food and Drug Administration. FDA Drug Safety Communication: Ongoing safety review of GnRH agonists and possible increased risk of diabetes and certain cardiovascular diseases. May 3, 2010. Available at: http://www.fda.gov/ Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ ucm209842.htm. Accessed March 28, 2011.
12. A.J. Friedman, D. Harrison-Atlas, R.L. Barbieri, B. Benacerraf, R. Gleason, and I. Schiff A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata Fertil Steril 51 1989 251 256 (Pubitemid 19050523)
13. A.J. Friedman, D.I. Hoffman, F. Comite, R.W. Browneller, and J.D. Miller Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo controlled, multicenter study. Leuprolide Study Group Obstet Gynecol 77 1991 720 725
14. W.H. Matta, R.W. Shaw, and M. Nye Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin BJOG 96 1989 200 206 (Pubitemid 19065473)
15. C.P. West, M.A. Lumsden, S. Lawson, J. Williamson, and D.T. Baird Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot Fertil Steril 48 1987 45 51 (Pubitemid 17093251)
16. W.H. Catherino, P.C. Leppert, M.H. Stenmark, M. Payson, C. Potlog-Nahari, L.K. Nieman, and J.H. Segars Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids Genes Chromosomes Cancer 40 2004 204 217 (Pubitemid 38703097)
17. R. Rogers, J. Norian, M. Malik, G. Christman, M. Abu-Asab, and F. Chen Mechanical homeostasis is altered in uterine leiomyoma Am J Obstet Gynecol 198 2008 474.e1 474.e11
18. C.L. Walker, and E.A. Stewart Uterine fibroid: the elephant in the room Science 308 2005 1589 1592
19. J.M. Norian, M. Malik, C.Y. Parker, D. Joseph, P.C. Leppert, and J.H. Segars Transforming growth factor β3 regulates the versican variants in the extracellular matrix-rick uterine leiomyomas Reprod Sci 16 2009 1153 1164
20. Q. Dou, R.W. Tarnuzzer, R.X. Williams, G.S. Schultz, and N. Chegini Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression Mol Hum Reprod 3 1997 1005 1014 (Pubitemid 127509967)
21. X. Luo, L. Ding, J. Xu, R.S. Williams, and N. Chegini Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin- releasing hormone analog therapy Endocrinology 146 2005 1074 1096 (Pubitemid 40289298)
22. N. Chegini, J. Verala, X. Luo, J. Xu, and R.S. Williams Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy J Soc Gynecol Investig 10 2003 161 171 (Pubitemid 36434150)
23. R. Dgani, B. Piura, G. Ben-Baruch, M. Open, M. Glezerman, and D. Nass Clinical-pathological study of uterine leiomyomas with high mitotic activity Acta Obstet Gynecol Scand 77 1998 74 77 (Pubitemid 28062368)
24. J.D. Parker, M.M. Malik, and W.H. Catherino Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor Fertil Steril 88 2007 39 46 (Pubitemid 47008919)
25. N. Chegini, H. Rong, Q. Dou, S. Kipersztok, and R.S. Williams Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro J Clin Endocrinol Metab 81 1996 3215 3221 (Pubitemid 26296191)
26. C. Lopez-Rodriguez, C.L. Antos, J.M. Shelton, J.A. Richardson, F. Lin, and T.I. Novobrantseva Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression Proc Natl Acad Sci USA 101 2004 2392 2397 (Pubitemid 38269322)
27. J.D. Ferraris, C.K. Williams, P. Persaud, Z. Zhang, Y. Chen, and M.B. Burg Activity of the TonEBP/OREBP transactivation domain varies directly with extracellular NaCl concentration Proc Natl Acad Sci USA 99 2002 739 744 (Pubitemid 34106580)
28. M.B. Burg, J.D. Ferraris, and N.I. Dmitrieva Cellular response to hyperosmotic stresses Physiol Rev 87 2007 1441 1474 (Pubitemid 350033825)
29. M.B. Burg, E.D. Kwon, and D. Kultz Regulation of gene expression by hypertonicity Annu Rev Physiol 59 1997 437 455 (Pubitemid 27142450)
30. A. Garcia-Perez, and M.B. Burg Renal medullary organic osmolytes Physiol Rev 71 1991 1081 1115
31. M. Malik, and W.H. Catherino Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays Fertil Steril 87 2007 1166 1172 (Pubitemid 46659932)
32. M. Malik, J. Webb, and W.H. Catherino Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells Clin Endocrinol 69 2008 462 470
33. K. Drews-Elger, M.C. Ortells, A. Rao, C. Lopez-Rodriguez, and J. Aramburu The transcription factor NFAT5 is required for cyclin expression and cell cycle progression in cells exposed to hypertonic stress PLoS One 4 2009 e5245
34. J.H. Lee, M. Kim, Y.S. Im, W. Choi, S.H. Byeon, and H.K. Lee NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells Invest Ophthalmol Vis Sci 49 2008 1827 1835
35. N. Chegini, C. Ma, X.M. Tang, and R.S. Williams Effects of GnRH analogues, "add-back" steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle growth and transforming growth factor-β expression Mol Hum Reprod 8 2002 1071 1078 (Pubitemid 36032844)
36. J. Xu, X. Luo, and A. Chegini Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration in gonadotropin-releasing hormone analog J Clin Endocrinol Metab 88 2003 1350 1361 (Pubitemid 36337800)
37. Q. Cai, J.D. Ferraris, and M.B. Burg High NaCl increases TonEBP/OREBP mRNA and protein by stabilizing its mRNA Am J Physiol Renal Physiol 289 2005 F803 F807
38. S.K. Woo, S.D. Lee, K.Y. Na, W.K. Park, and H.M. Kwon TonEBP/NFAT5 stimulates transcription of HSP70 in response to hypertonicity Mol Cell Biol 22 2002 5753 5760 (Pubitemid 34815824)
39. M.L. Loyher, M. Mutin, S.K. Woo, H.M. Kwon, and M.L. Tappaz Transcription factor tonicity-responsive enhancer-binding protein (TonEBP) which transactivates osmoprotective genes is expressed and upregulated following acute systemic hypertonicity in neurons in brain Neuroscience 124 2004 89 104 (Pubitemid 38186620)
40. J.A. Arroyo, C. Teng, F.C. Battaglia, and H.L. Galan Determination of the NFAT5/TonEBP transcription factor in the human and ovine placenta Syst Biol Reprod Med 55 2009 164 170
41. T. Kino, H. Takatori, I. Manoli, Y. Wang, A. Tiulpakov, and M.R. Blackman Brx mediates the response of lymphocytes to osmotic stress through activation of NFAT5 Sci Signal 2 2009 ra5.1 ra5.15
42. F. Guilak, G.R. Erickson, and H.P. Ting-Beall The effects of osmotic stress on the viscoelastic and physical properties of articular chondrocytes Biophys J 82 2002 720 727 (Pubitemid 34111213)
43. H.P. Ting-Beall, D. Needham, and R.M. Hochmuth Volume and osmotic properties of human neutrophils Blood 81 1993 2774 2780 (Pubitemid 23147586)